Publications by the researcher in collaboration with SUSANA TORRADO DURÁN (25)

2017

  1. Improvement of the surface hydrophilic properties of naproxen particles with addition of hydroxypropylmethyl cellulose and sodium dodecyl sulphate: In vitro and in vivo studies

    International Journal of Pharmaceutics, Vol. 529, Núm. 1-2, pp. 381-390

2016

  1. New Multi-Particle Systems for Colon-Targeted Meloxicam

    Journal of Applied Pharmacy, Vol. 8, Núm. 3, pp. 1-3

2015

  1. Novel solid dispersions of benznidazole: Preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system

    Experimental Parasitology, Vol. 149, pp. 84-91

2014

  1. Development of novel benznidazole formulations: Physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease

    International Journal of Pharmaceutics, Vol. 472, Núm. 1-2, pp. 110-117

  2. Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose

    Drug Design, Development and Therapy, Vol. 8, pp. 1467-1479

2012

  1. The Influence of CYP2C19 Genetic Polymorphism on the Pharmacokinetics/- Pharmacodynamics of Proton Pump Inhibitor-Containing Helicobacter pylori Treat-ments

    Current Drug Metabolism, Vol. 13, Núm. 9, pp. 1303-1312

2011

  1. Changed crystallinity of mebendazole solid dispersion: Improved anthelmintic activity

    International Journal of Pharmaceutics, Vol. 403, Núm. 1-2, pp. 23-28

2004

  1. Chitosan-poly(acrylic) acid polyionic complex: In vivo study to demonstrate prolonged gastric retention

    Biomaterials, Vol. 25, Núm. 5, pp. 917-923

2003

  1. Interpolymer complexes of poly(acrylic acid) and chitosan: Influence of the ionic hydrogel-forming medium

    Biomaterials, Vol. 24, Núm. 8, pp. 1459-1468

2002

  1. Characterization of physical state of mannitol after freeze-drying: Effect of acetylsalicylic acid as a second crystalline cosolute

    Chemical and Pharmaceutical Bulletin, Vol. 50, Núm. 5, pp. 567-570

1999

  1. Preparation, dissolution and characterization of praziquantel solid dispersions

    Chemical and Pharmaceutical Bulletin, Vol. 47, Núm. 11, pp. 1629-1633

1998

  1. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: The influence of the dose-regime

    Veterinary Parasitology, Vol. 75, Núm. 2-3, pp. 209-219

  2. Process-induced crystallite size and dissolution changes elucidated by a variety of analytical methods

    International Journal of Pharmaceutics, Vol. 166, Núm. 1, pp. 55-63

1997

  1. A novel formulation of albendazole solution: Oral bioavailability and efficacy evaluation

    International Journal of Pharmaceutics, Vol. 156, Núm. 2, pp. 181-187

  2. Improvement of albendazole efficacy against enteral, but not against parenteral stages of trichinella spiralis by preparing solid dispersions in polyvinylpyrrolidone

    Chemotherapy, Vol. 43, Núm. 6, pp. 430-435

1996

  1. Egg albumin microaggregates containing colistin for oral administration: Organoleptic characteristics

    Drug Development and Industrial Pharmacy, Vol. 22, Núm. 5, pp. 451-456

  2. Formulation parameters of albendazole solution

    International Journal of Pharmaceutics, Vol. 140, Núm. 1, pp. 45-50

  3. Preparation, dissolution and characterization of albendazole solid dispersions

    International Journal of Pharmaceutics, Vol. 140, Núm. 2, pp. 247-250

1995

  1. Effect of dissolution profile and (-)-α-bisabolol on the gastrotoxicity of acetylsalicylic acid

    Pharmazie, Vol. 50, Núm. 2, pp. 141-143

1994

  1. AAS formulations: Dissolution profile and gastrotoxicity

    Proceedings of the Controlled Release Society